1 Min Read
Dec 19 (Reuters) - Gilead Sciences Inc :
* Gilead - Japan’s Ministry of Health, Labour and Welfare approves Gilead’s Vemlidy for patients with chronic Hepatitis B virus infection Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.